HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Paul Van Schil Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Van Schil, P. Search for Related Content PubMed Articles by Van Schil, P. Related Collections Lung - cancer

Ann Thorac Surg 2004;77:259
© 2004 The Society of Thoracic Surgeons

---

Original article: general thoracic

Invited commentary

Department of Thoracic and Vascular Surgery, University Hospital of Antwerp, Wilrijkstraat 10, B-2650 Edegem Belgium

e-mail: paul.van.schil@uza.be

The first 20% of the full text of this article appears below.

Precise restaging after induction or neoadjuvant therapy is important to accurately determine response after chemotherapy or chemoradiotherapy and to decide on further treatment. This is especially relevant in patients with N2 disease as prognosis is poor in the case of persisting mediastinal involvement, and these patients will not benefit from surgical resection.

Classical imaging techniques as computed tomography (CT) and magnetic resonance imaging have a low accuracy in restaging the primary tumor and mediastinum. Initial reports on positron emission tomography (PET), which . . . [Full Text of this Article]

This article has been cited by other articles:

				W A Weber PET for response assessment in oncology: radiotherapy and chemotherapy Br. J. Radiol., November 1, 2005; Supplement_28(1): 42 - 49. [Abstract] [Full Text] [PDF]